Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results from the GALACTIC-HF study

We examined the relationship between baseline troponin, change in troponin over time, and the treatment effect of omecamtiv mecarbil in patients enrolled in the Global Approach to Lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure (GALACTIC-HF) trial (NCT02929329).

Source: Journal of Cardiac Failure - January 10, 2024 Category: Cardiology Authors: G. Michael Felker, Scott D. Solomon, Marco Metra, John J.V. McMurray, Rafael Diaz, Brian Claggett, David E. Lanfear, Hans Vandekerckhove, Tor Biering-S ørensen, Renato D. Lopes, Alexandra Arias-Mendoza, Shin-ichi Momomura, Ramon Corbalan, Felix J.A. Rami Source Type: research